Vaginosis POC test gets CE mark, 11/17
November 2017—Mologic (Thurleigh, U.K.) received CE marking for its BVPro, a 15-minute point-of-care diagnostic that detects sialidase enzyme activity from a vaginal swab sample.
Webinars and Sponsored Roundtables — Register Now
Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.
Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 10, 2026, 1 PM-2 PM ET
Join us for a session to help improve diagnostic accuracy in your practice when scoring HER2 IHC 0 with faint, incomplete membrane staining in ≤10% of tumor cells vs IHC 0 with no membrane staining detected in patients with mBC.
Webinar presenter Jeffrey Gregg, MD, University of Nevada
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace Directory
iBio, TheoremDx partnership, 11/17
November 2017—iBio has partnered with TheoremDx to develop proteins for rapid diagnostic testing products. The collaboration will leverage the TheoremDx point-of-care diagnostic system and the protein development and manufacturing capabilities
FDA clears iCubate platform, 11/17
November 2017—Molecular diagnostic device company iCubate has earned FDA clearance for its iCubate platform, the iC-System, and its first clinical assay, the iC-GPC Assay, used for the rapid detection of pathogenic bacteria associated with bloodstream infection.
High-throughput water purification system, 11/17
November 2017—MilliporeSigma launched its Milli-Q HR 7000 series, a high-throughput water purification system that offers a uniquely connected and sustainable central pure water solution. The system ensures constant water quality and flow rate while reducing water consumption and running costs, as compared with other high-throughput reverse osmosis systems, and produces up to 13,000 liters of pure water daily.
Urinalysis testing device, 11/17
November 2017—Quantimetrix announced that the U.S. Patent and Trademark Office issued a Notice of Allowance for the company’s Dipper POCT Urinalysis Control. The patent application is directed to a liquid holding apparatus for insertion of a test device into a test liquid. The invention includes various technical innovations relating to the formation and use of an in vitro diagnostic pouch device.
Small, dense LDL assay cleared, 11/17
November 2017—Denka Seiken has received FDA 510(k) clearance for its small, dense LDL cholesterol (sdLDL-C) assay, designed for use with automated chemistry analyzers.
Varicella zoster virus antigens, 11/17
November 2017—Binding Site’s Immunologicals Group has added two varicella zoster virus antigens to its line of products for in vitro diagnostic manufacturing and research applications. Both the standard VZV antigen and the VZV glycoprotein antigen have been designed for use as integral components within solid phase enzyme immunoassay test procedures.
Automated section mounting system, 11/17
November 2017—Aquaro Histology exhibited its AquaroASM, the company’s device for automating microtomy, at the 43rd Annual National Society for Histotechnology Symposium/Convention in September.
Commercializing novel IVDs book, 10/17
October 2017—Insight Pharma Reports has published Commercializing Novel IVDs: A Comprehensive Manual for Success by Harry Glorikian, MBA, who has more than 30 years in the global IVD field and in IVD innovation.
NWLP inks deal with Abbott, 10/17
October 2017—North West London Pathology, hosted by Imperial College Healthcare NHS Trust, and Abbott have signed a $252 million managed equipment services contract for the supply of all analytical equipment and consumables, including Abbott’s Alinity ci and Alinity h series diagnostics instruments as well as its professional services and informatics solutions known as AlinIQ.